Cognizant Collaborates with Medidata to Provide Specialized Support for Life Sciences Clients

Core Insights - Cognizant has announced an expanded agreement with Medidata to enhance support for life sciences clients and improve clinical trial development through AI-powered technologies [1][3] Partnership Details - The renewed multi-year agreement includes a dedicated team of Medidata Platform specialists to assist clients in pharmaceutical, biotech, medical device, and contract research organizations [2] - The collaboration aims to maximize Medidata's value for life sciences clients, focusing on improving user experience and patient outcomes [2][4] Technological Integration - The partnership combines Medidata's advanced AI-driven technologies with Cognizant's industry knowledge to streamline R&D efforts and derive actionable insights from complex data [3] - Solutions such as Medidata Clinical Data Studio, Medidata Health Record Connect, and the myMedidata patient portal are part of the initiative to transform R&D experiences [3] Strategic Goals - The collaboration seeks to unlock the full potential of clients' clinical data and processes, enhancing user satisfaction and enabling faster, better-informed decision-making [4]